ASH 2018: Expert overview of the latest in CLL, ALL and AML

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

Determining the prognosis of patients with myelodysplastic syndromes using machine learning

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

ECHELON-2: a large peripheral T-cell lymphoma trial

Link between gut microbiota and haematopoietic cell transplantation outcomes

Initial report of the Beat AML umbrella study for previously untreated AML

Machine learning algorithm improves prognosis accuracy for patients with myelodysplastic syndromes

Diversity of gut microbiota linked with complications from haematopoietic cell transplantation

Progression-free survival milestones in primary central nervous system lymphoma